A recent U.S. military strike on a suspected drug boat in the Eastern Pacific resulted in six fatalities, contributing to a rising death toll linked to anti-drug operations.
Today's health news highlights the growth of an international childhood vaccine campaign alongside a shift in GOP drug policy, signaling significant changes in public health efforts.
President Trump has finalized a series of drug pricing agreements, with the last deal involving Regeneron, marking the conclusion of 17 agreements pursued by the White House.
A multiple sclerosis treatment from Sanofi has received a positive review in Europe, marking a notable shift after its rejection by the FDA last year.
Dawn Zuidegeest-Craft shares her experience of starting medical school at 69 and now preparing for residency at 72, highlighting the challenges and lessons learned.
The treatment of health and science reporting as optional is a significant oversight that impacts public health.
Recent studies using neutron scattering techniques have shed light on how proteins operate in densely packed cellular settings, highlighting their vital roles in various functions.
As Europe grapples with an energy crisis, MEPs engage in heated discussions about the continent's energy strategy in the latest edition of The Ring.
In a notable shift from previous GOP stances, the Trump administration is now supporting research into psychedelics and reconsidering marijuana's legal status.
Recent research utilizing advanced analytical techniques has uncovered the presence of certain pathogens in ancient Roman remains, suggesting a more complex understanding of their health and hygiene.
In a notable policy shift, President Trump has reclassified state-licensed medical marijuana as a less-dangerous drug, a change that advocates have long pursued.
Legislators in Colorado and Virginia are opposing efforts to limit the powers of prescription drug affordability boards, highlighting a significant debate over drug pricing strategies.
Federal regulators are set to unveil a new Medicare coverage pathway aimed at accelerating access to FDA-designated breakthrough medical devices, enhancing treatment options for patients.
In a recent shift, RFK Jr. has expressed support for vaccinations while also defending his previous secret agreements with pharmaceutical companies.
The Nuclear Energy Agency (NEA) recently convened a workshop to explore advancements and challenges in the supply of medical radioisotopes.
A recent discovery by researchers at the University of Toronto reveals that certain bacteria can transform waste into valuable chemicals, potentially transforming the cosmetics industry.
In a notable shift, Kennedy is adjusting his approach to MAHA, stepping back from several key issues while still making an impact in health care.
The appointment of a former Imperial Brands executive to a senior position at the CDC has sparked concerns about potential tobacco industry influence within the agency.
Robert F. Kennedy Jr. is set to testify before the Senate's health care panel today. Viewers can watch the proceedings live as he addresses the committee.
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.